Clinical Report: Comprehensive Toxicological Systems Approach Reveals TCDD-Responsive Targets
Overview
This study identifies 87 genes associated with TCDD exposure and psoriasis, highlighting their involvement in immune dysfunction and treatment outcomes. Key findings include the upregulation of five core target genes linked to local immune infiltration patterns and treatment response.
Background
Psoriasis is a chronic inflammatory skin disease driven by immune dysregulation, particularly involving the IL-23/IL-17 axis. Understanding the role of environmental pollutants like TCDD in psoriasis pathogenesis is crucial, as they may contribute to disease exacerbation and treatment variability. This study explores the molecular mechanisms by which TCDD may influence psoriasis, providing insights into potential therapeutic targets.
Data Highlights
No numerical data or trial data presented.
Key Findings
Identification of 87 overlapping genes between TCDD-related targets and psoriasis-associated genes.
Core target genes LCK, MMP9, CXCR2, PTAFR, and CCNB1 were significantly upregulated in psoriatic lesions.
Machine learning analysis demonstrated strong diagnostic performance of the core genes within the analyzed datasets.
Higher baseline MMP9 levels were associated with poorer clinical improvement in biologic therapy cohorts.
Structural analyses indicated potential interactions between TCDD and core targets, particularly with CXCR2.
Clinical Implications
The findings suggest that monitoring the expression of core genes may provide insights into treatment responses in psoriasis patients. Additionally, understanding the impact of environmental factors like TCDD could inform future therapeutic strategies.
Conclusion
The study highlights the potential role of TCDD in psoriasis immune dysregulation and underscores the need for further validation in cohort studies to establish a direct link between environmental exposure and disease outcomes.
